SETD2 and enteropathy-associated T-cell lymphoma: Possible biomarkers for EATL via liquid biopsy might be JAK1/STAT3 mutations, SETD2 mutations, and T-cell receptor (TCR) clonality, but their clinical utility in EATL remains largely exploratory [29].